A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome (Q46129530)
Jump to navigation
Jump to search
scientific article published on 18 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome |
scientific article published on 18 June 2008 |
Statements
1 reference
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome (English)
1 reference
Mark Speakman
1 reference
Vik Khullar
1 reference
Anthony Mundy
1 reference
Isaac Odeyemi
1 reference
John Bolodeoku
1 reference
18 June 2008
1 reference
24
1 reference
8
1 reference
2173-2179
1 reference